Auditors changed, announce delisting, buy back at the subsequent low price, director can sell into it. Think we can just hold on and hope we can get a little better price. Seems all OK with our timid regulator.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025